Oral delivery of the appetite suppressing peptide hPYY(3-36) through the Vitamin B 12 uptake pathway

Christopher H. Fazen, Debbie Valentin, Timothy J. Fairchild, Robert Patrick Doyle

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

hPYY(3-36) injections have shown positive effects on appetite regulations, sparking increased interest in hPYY(3-36) research. Of great interest is oral delivery of hPYY(3-36) that can achieve clinically relevant weight-loss outcomes in what would be a highly patient compliant route. Successful oral delivery of other peptides utilizing the vitamin B 12 pathway has been shown but below clinically relevant levels. Herein, we present clinically relevant in vivo oral delivery of B 12-hPYY(3-36) conjugates.

Original languageEnglish (US)
Pages (from-to)8707-8711
Number of pages5
JournalJournal of Medicinal Chemistry
Volume54
Issue number24
DOIs
StatePublished - Dec 22 2011

Fingerprint

Appetite Regulation
Appetite
Vitamin B 12
Weight Loss
Peptides
Injections
Research

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

Oral delivery of the appetite suppressing peptide hPYY(3-36) through the Vitamin B 12 uptake pathway. / Fazen, Christopher H.; Valentin, Debbie; Fairchild, Timothy J.; Doyle, Robert Patrick.

In: Journal of Medicinal Chemistry, Vol. 54, No. 24, 22.12.2011, p. 8707-8711.

Research output: Contribution to journalArticle

Fazen, Christopher H. ; Valentin, Debbie ; Fairchild, Timothy J. ; Doyle, Robert Patrick. / Oral delivery of the appetite suppressing peptide hPYY(3-36) through the Vitamin B 12 uptake pathway. In: Journal of Medicinal Chemistry. 2011 ; Vol. 54, No. 24. pp. 8707-8711.
@article{b09583a7d2474d26b05c2ec97a3063cc,
title = "Oral delivery of the appetite suppressing peptide hPYY(3-36) through the Vitamin B 12 uptake pathway",
abstract = "hPYY(3-36) injections have shown positive effects on appetite regulations, sparking increased interest in hPYY(3-36) research. Of great interest is oral delivery of hPYY(3-36) that can achieve clinically relevant weight-loss outcomes in what would be a highly patient compliant route. Successful oral delivery of other peptides utilizing the vitamin B 12 pathway has been shown but below clinically relevant levels. Herein, we present clinically relevant in vivo oral delivery of B 12-hPYY(3-36) conjugates.",
author = "Fazen, {Christopher H.} and Debbie Valentin and Fairchild, {Timothy J.} and Doyle, {Robert Patrick}",
year = "2011",
month = "12",
day = "22",
doi = "10.1021/jm2012547",
language = "English (US)",
volume = "54",
pages = "8707--8711",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "24",

}

TY - JOUR

T1 - Oral delivery of the appetite suppressing peptide hPYY(3-36) through the Vitamin B 12 uptake pathway

AU - Fazen, Christopher H.

AU - Valentin, Debbie

AU - Fairchild, Timothy J.

AU - Doyle, Robert Patrick

PY - 2011/12/22

Y1 - 2011/12/22

N2 - hPYY(3-36) injections have shown positive effects on appetite regulations, sparking increased interest in hPYY(3-36) research. Of great interest is oral delivery of hPYY(3-36) that can achieve clinically relevant weight-loss outcomes in what would be a highly patient compliant route. Successful oral delivery of other peptides utilizing the vitamin B 12 pathway has been shown but below clinically relevant levels. Herein, we present clinically relevant in vivo oral delivery of B 12-hPYY(3-36) conjugates.

AB - hPYY(3-36) injections have shown positive effects on appetite regulations, sparking increased interest in hPYY(3-36) research. Of great interest is oral delivery of hPYY(3-36) that can achieve clinically relevant weight-loss outcomes in what would be a highly patient compliant route. Successful oral delivery of other peptides utilizing the vitamin B 12 pathway has been shown but below clinically relevant levels. Herein, we present clinically relevant in vivo oral delivery of B 12-hPYY(3-36) conjugates.

UR - http://www.scopus.com/inward/record.url?scp=84055176224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84055176224&partnerID=8YFLogxK

U2 - 10.1021/jm2012547

DO - 10.1021/jm2012547

M3 - Article

C2 - 22054008

AN - SCOPUS:84055176224

VL - 54

SP - 8707

EP - 8711

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 24

ER -